VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism

被引:555
作者
Gerber, HP
Malik, AK
Solar, GP
Sherman, D
Liang, XH
Meng, G
Hong, K
Marsters, JC
Ferrara, N
机构
[1] Genentech Inc, Dept Mol Oncol, San Francisco, CA 94080 USA
[2] Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA
[3] Genentech Inc, Dept Assay Dev, San Francisco, CA 94080 USA
[4] Genentech Inc, Dept Organ Chem, San Francisco, CA 94080 USA
基金
英国惠康基金;
关键词
D O I
10.1038/nature00821
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Vascular endothelial growth factor (VEGF) is a principal regulator of blood vessel formation and haematopoiesis(1,2), but the mechanisms by which VEGF differentially regulates these processes have been elusive. Here we describe a regulatory loop by which VEGF controls survival of haematopoietic stem cells (HSCs). We observed a reduction in survival, colony formation and in vivo repopulation rates of HSCs after ablation of the VEGF gene in mice. Intracellularly acting small-molecule inhibitors of VEGF receptor (VEGFR) tyrosine kinase dramatically reduced colony formation of HSCs, thus mimicking deletion of the VEGF gene. However, blocking VEGF by administering a soluble VEGFR-1, which acts extracellularly, induced only minor effects. These findings support the involvement in HSC survival of a VEGF-dependent internal autocrine loop mechanism (that is, the mechanism is resistant to inhibitors that fail to penetrate the intracellular compartment). Not only ligands selective for VEGF and VEGFR-2 but also VEGFR-1 agonists rescued survival and repopulation of VEGF-deficient HSCs, revealing a function for VEGFR-1 signalling during haematopoiesis.
引用
收藏
页码:954 / 958
页数:6
相关论文
共 30 条
  • [11] Gerber HP, 2000, CANCER RES, V60, P6253
  • [12] Gerber HP, 1999, DEVELOPMENT, V126, P1149
  • [13] Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′-kinase Akt signal transduction pathway -: Requirement for Flk-1/KDR activation
    Gerber, HP
    McMurtrey, A
    Kowalski, J
    Yan, MH
    Keyt, BA
    Dixit, V
    Ferrara, N
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (46) : 30336 - 30343
  • [14] GILLE H, 2000, J BIOL CHEM, V10, P3222
  • [15] Design and structure-activity relationship of a new class of potent VEGF receptor tyrosine kinase inhibitors
    Hennequin, LF
    Thomas, AP
    Johnstone, C
    Stokes, ESE
    Plé, PA
    Lohmann, JJM
    Ogilvie, DJ
    Dukes, M
    Wedge, SR
    Curwen, JO
    Kendrew, J
    Lambert-van der Brempt, C
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (26) : 5369 - 5389
  • [16] Autocrine/paracrine mechanisms in human hematopoiesis
    Janowska-Wieczorek, A
    Majka, M
    Ratajczak, J
    Ratajczak, MZ
    [J]. STEM CELLS, 2001, 19 (02) : 99 - 107
  • [17] Kabrun N, 1997, DEVELOPMENT, V124, P2039
  • [18] Inhibition of VEGF receptors causes lung cell apoptosis and emphysema
    Kasahara, Y
    Tuder, RM
    Taraseviciene-Stewart, L
    Le Cras, TD
    Abman, S
    Hirth, PK
    Waltenberger, J
    Voelkel, NF
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2000, 106 (11) : 1311 - 1319
  • [19] EXPRESSION OF A HEMATOPOIETIC GROWTH-FACTOR CDNA IN A FACTOR-DEPENDENT CELL-LINE RESULTS IN AUTONOMOUS GROWTH AND TUMORIGENICITY
    LANG, RA
    METCALF, D
    GOUGH, NM
    DUNN, AR
    GONDA, TJ
    [J]. CELL, 1985, 43 (02) : 531 - 542
  • [20] Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth
    Lyden, D
    Hattori, K
    Dias, S
    Costa, C
    Blaikie, P
    Butros, L
    Chadburn, A
    Heissig, B
    Marks, W
    Witte, L
    Wu, Y
    Hicklin, D
    Zhu, ZP
    Hackett, NR
    Crystal, RG
    Moore, MAS
    Hajjar, KA
    Manova, K
    Benezra, R
    Rafii, S
    [J]. NATURE MEDICINE, 2001, 7 (11) : 1194 - 1201